All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated LoansInvestment Grade Loans

GSK’s ratings under pressure with Novartis buy

Glaxo 230x150 Brentford HQ

UK drug maker GlaxoSmithKline has agreed to buy Novartis’s 36.5% stake in the pair’s consumer healthcare joint venture, just days after backing out of an acquisition for a similar Pfizer unit.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree